Search

everythinglearnresearchcommunity

for

Search:↓

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Alopecia areata involves immune response and gene changes affecting hair loss.

New psoriasis treatments are effective but come with side effects and risks.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Hair loss treatment caused more hair loss in a man.

The dog with an Alopecia Areata-like condition showed signs of an autoimmune disease and partially regrew hair without treatment, suggesting dogs could be models for human AA research.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.

A man in Japan got better from a scalp fungal infection using terbinafine.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

A man developed a skin cancer called folliculotropic mycosis fungoides after a kidney transplant.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Dandruff is linked to changes in the immune system of hair follicles and skin.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

The combination of oral PUVA and corticosteroids helps regrow hair in severe alopecia areata.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

The research identified unique metabolic activities in immune cells associated with hair loss in Alopecia Areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.